Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046438
Filing Date
2024-11-18
Accepted
2024-11-18 09:00:02
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 851306
2 ex31-1.htm EX-31.1 14716
3 ex31-2.htm EX-31.2 14675
4 ex32-1.htm EX-32.1 6703
5 ex32-2.htm EX-32.2 6672
  Complete submission text file 0001493152-24-046438.txt   4234621

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acut-20240930.xsd EX-101.SCH 26470
7 XBRL CALCULATION FILE acut-20240930_cal.xml EX-101.CAL 33281
8 XBRL DEFINITION FILE acut-20240930_def.xml EX-101.DEF 98051
9 XBRL LABEL FILE acut-20240930_lab.xml EX-101.LAB 240863
10 XBRL PRESENTATION FILE acut-20240930_pre.xml EX-101.PRE 180488
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 757254
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56257 | Film No.: 241469862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)